SG10201905229VA - Anti-Dengue Virus Antibodies and Applications Thereof - Google Patents
Anti-Dengue Virus Antibodies and Applications ThereofInfo
- Publication number
- SG10201905229VA SG10201905229VA SG10201905229VA SG10201905229VA SG10201905229VA SG 10201905229V A SG10201905229V A SG 10201905229VA SG 10201905229V A SG10201905229V A SG 10201905229VA SG 10201905229V A SG10201905229V A SG 10201905229VA SG 10201905229V A SG10201905229V A SG 10201905229VA
- Authority
- SG
- Singapore
- Prior art keywords
- applications
- dengue virus
- virus antibodies
- antibodies
- dengue
- Prior art date
Links
- 208000001490 Dengue Diseases 0.000 title 1
- 206010012310 Dengue fever Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 208000025729 dengue disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
- G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/006,000 US10526398B2 (en) | 2018-06-12 | 2018-06-12 | Anti-dengue virus antibodies and applications thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201905229VA true SG10201905229VA (en) | 2020-01-30 |
Family
ID=68764028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201905229VA SG10201905229VA (en) | 2018-06-12 | 2019-06-10 | Anti-Dengue Virus Antibodies and Applications Thereof |
Country Status (3)
Country | Link |
---|---|
US (1) | US10526398B2 (en) |
CN (1) | CN110590943B (en) |
SG (1) | SG10201905229VA (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112444628B (en) * | 2020-12-07 | 2022-08-02 | 中国检验检疫科学研究院 | Method for establishing dengue virus high-sensitivity detection based on nano magnetic bead immunochromatography technology |
CN115785262B (en) * | 2021-09-10 | 2023-09-22 | 东莞市朋志生物科技有限公司 | Antibody for resisting dengue NS1 protein and application thereof |
CN116082499B (en) * | 2021-11-08 | 2023-10-27 | 东莞市朋志生物科技有限公司 | Antibody for resisting dengue NS1 protein and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012082073A1 (en) * | 2010-12-14 | 2012-06-21 | National University Of Singapore | Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
CN102757498A (en) * | 2011-04-26 | 2012-10-31 | 中国人民解放军第二军医大学 | Bifunctional antibody for resisting four serotype dengue viruses and application thereof in preparation of drugs for resisting dengue virus infection |
US20140349321A1 (en) * | 2011-12-16 | 2014-11-27 | Agency For Science, Technology And Research | Binding molecules against dengue virus and uses thereof |
CN107531779B (en) * | 2015-03-17 | 2021-04-13 | 新加坡科技研究局 | Serotype cross-reactive dengue neutralizing antibodies and uses thereof |
WO2017011495A1 (en) * | 2015-07-14 | 2017-01-19 | Vanderbilt University | Engineered antibodies against dengue virus |
TWI769185B (en) * | 2016-10-27 | 2022-07-01 | 海樂源有限公司 | Dengue virus-like particle, antibody against dengue virus, and composition comprising the same |
-
2018
- 2018-06-12 US US16/006,000 patent/US10526398B2/en active Active
-
2019
- 2019-06-10 SG SG10201905229VA patent/SG10201905229VA/en unknown
- 2019-06-12 CN CN201910505187.3A patent/CN110590943B/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20190375826A1 (en) | 2019-12-12 |
US10526398B2 (en) | 2020-01-07 |
CN110590943B (en) | 2022-11-25 |
CN110590943A (en) | 2019-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276950A (en) | Anti-cd73 antibodies and uses thereof | |
IL282968A (en) | Anti-nkg2a antibodies and uses thereof | |
SG11202105885WA (en) | Anti-claudin antibodies and uses thereof | |
IL284044A (en) | Antibodies that neutralize hepatitis b virus and uses thereof | |
IL275826A (en) | Anti-mct1 antibodies and uses thereof | |
IL289585A (en) | Dll3-targeting antibodies and uses thereof | |
IL281297A (en) | Anti-npr1 antibodies and uses thereof | |
SG11202009772PA (en) | Anti-dll3 antibodies and uses thereof | |
SG11202009625WA (en) | Anti-trem-1 antibodies and uses thereof | |
IL280321A (en) | Anti-cxcr2 antibodies and uses thereof | |
IL277330A (en) | Anti-il-27 antibodies and uses thereof | |
SG11202112112UA (en) | Anti-galectin-9 antibodies and uses thereof | |
IL283875A (en) | Anti-il-27 antibodies and uses thereof | |
IL281202A (en) | Anti-tnfrsf9 antibodies and uses thereof | |
IL277075A (en) | Anti-phf-tau antibodies and uses thereof | |
IL276548A (en) | Bcma-binding antibodies and uses thereof | |
IL289656A (en) | Anti-tigit antibodies and application thereof | |
SG11202012680TA (en) | Anti-l1cam antibodies and uses thereof | |
IL291027A (en) | Anti-steap1 antibodies and uses thereof | |
SG10201905229VA (en) | Anti-Dengue Virus Antibodies and Applications Thereof | |
IL283926A (en) | Anti-alpha-synuclein antibodies and uses thereof | |
IL291546A (en) | Anti-kir3dl3 antibodies and uses thereof | |
IL291550A (en) | Anti-il-27 antibodies and uses thereof | |
IL291280A (en) | Anti-cd371 antibodies and uses thereof | |
IL283890A (en) | Anti-periostin antibodies and uses thereof |